fanta.bio Sample: CNhs11952
17846 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1172 / 14979 (7.8%) | 406 / 149790 (0.3%) | −324.0 | −324.0 | 28.87 |
| HIF1A SRX11007095 | HK-2 Kidney | 2310 / 14979 (15.4%) | 827 / 149790 (0.6%) | −324.0 | −324.0 | 27.93 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1726 / 14979 (11.5%) | 678 / 149790 (0.5%) | −324.0 | −324.0 | 25.46 |
| HIF1A SRX20663235 | HK-2 Kidney | 503 / 14979 (3.4%) | 240 / 149790 (0.2%) | −324.0 | −324.0 | 20.96 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1573 / 14979 (10.5%) | 751 / 149790 (0.5%) | −324.0 | −324.0 | 20.95 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2245 / 14979 (15.0%) | 1122 / 149790 (0.7%) | −324.0 | −324.0 | 20.01 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2157 / 14979 (14.4%) | 1084 / 149790 (0.7%) | −324.0 | −324.0 | 19.90 |
| SCML2 SRX644728 | 293 Kidney | 1264 / 14979 (8.4%) | 733 / 149790 (0.5%) | −324.0 | −324.0 | 17.24 |
| FOXP1 SRX736067 | LNCAP Prostate | 1701 / 14979 (11.4%) | 1101 / 149790 (0.7%) | −324.0 | −324.0 | 15.45 |
| BRD4 SRX9419935 | BT-474 Breast | 3660 / 14979 (24.4%) | 2474 / 149790 (1.7%) | −324.0 | −324.0 | 14.79 |
| MED1 SRX9419945 | BT-474 Breast | 3582 / 14979 (23.9%) | 2515 / 149790 (1.7%) | −324.0 | −324.0 | 14.24 |
| BRD4 SRX9419937 | BT-474 Breast | 3603 / 14979 (24.1%) | 2537 / 149790 (1.7%) | −324.0 | −324.0 | 14.20 |
| MED1 SRX9419944 | BT-474 Breast | 3490 / 14979 (23.3%) | 2492 / 149790 (1.7%) | −324.0 | −324.0 | 14.00 |
| MYH11 SRX265221 | ME-1 Blood | 799 / 14979 (5.3%) | 579 / 149790 (0.4%) | −324.0 | −324.0 | 13.80 |
| BRD4 SRX9419936 | BT-474 Breast | 3662 / 14979 (24.4%) | 2656 / 149790 (1.8%) | −324.0 | −324.0 | 13.79 |
| MED1 SRX9419946 | BT-474 Breast | 3648 / 14979 (24.4%) | 2659 / 149790 (1.8%) | −324.0 | −324.0 | 13.72 |
| BRD4 SRX9419938 | BT-474 Breast | 3631 / 14979 (24.2%) | 2664 / 149790 (1.8%) | −324.0 | −324.0 | 13.63 |
| MED1 SRX9419947 | BT-474 Breast | 3526 / 14979 (23.5%) | 2610 / 149790 (1.7%) | −324.0 | −324.0 | 13.51 |
| EZH2 SRX2146136 | LNCAP Prostate | 7683 / 14979 (51.3%) | 7303 / 149790 (4.9%) | −324.0 | −324.0 | 10.52 |
| BRD4 SRX736201 | 90-8TL Neural | 5711 / 14979 (38.1%) | 6112 / 149790 (4.1%) | −324.0 | −324.0 | 9.34 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 732 / 14979 (4.9%) | 842 / 149790 (0.6%) | −324.0 | −324.0 | 8.69 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1649 / 14979 (11.0%) | 2396 / 149790 (1.6%) | −324.0 | −324.0 | 6.88 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1383 / 14979 (9.2%) | 3306 / 149790 (2.2%) | −324.0 | −324.0 | 4.18 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1712 / 14979 (11.4%) | 4521 / 149790 (3.0%) | −324.0 | −324.0 | 3.79 |
| 5-mC SRX882970 | LNCAP Prostate | 3020 / 14979 (20.2%) | 13425 / 149790 (9.0%) | −324.0 | −324.0 | 2.25 |
| 5-mC SRX882968 | LNCAP Prostate | 2983 / 14979 (19.9%) | 13364 / 149790 (8.9%) | −324.0 | −324.0 | 2.23 |
| RUNX1 SRX2513054 | 293 Kidney | 3308 / 14979 (22.1%) | 15791 / 149790 (10.5%) | −324.0 | −324.0 | 2.09 |
| PBX4 SRX2731658 | PC-3 Prostate | 589 / 14979 (3.9%) | 23555 / 149790 (15.7%) | −324.0 | −324.0 | 0.25 |
| YAP1 SRX757325 | H2052 Lung | 432 / 14979 (2.9%) | 18153 / 149790 (12.1%) | −324.0 | −324.0 | 0.24 |
| FOS SRX150477 | MCF 10A Breast | 416 / 14979 (2.8%) | 17363 / 149790 (11.6%) | −321.4 | −318.3 | 0.24 |
| FOS SRX150478 | MCF 10A Breast | 446 / 14979 (3.0%) | 17857 / 149790 (11.9%) | −320.1 | −317.0 | 0.25 |
| TP53 SRX19538279 | Osteoblasts Bone | 492 / 14979 (3.3%) | 261 / 149790 (0.2%) | −316.5 | −313.5 | 18.85 |
| YAP1 SRX757326 | H2052 Lung | 369 / 14979 (2.5%) | 16194 / 149790 (10.8%) | −310.2 | −307.2 | 0.23 |
| AGO2 SRX4708039 | Hep G2 Liver | 1899 / 14979 (12.7%) | 6651 / 149790 (4.4%) | −309.9 | −306.9 | 2.86 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 403 / 14979 (2.7%) | 16796 / 149790 (11.2%) | −309.6 | −306.6 | 0.24 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 679 / 14979 (4.5%) | 831 / 149790 (0.6%) | −296.7 | −293.7 | 8.17 |
| 5-mC SRX882965 | LNCAP Prostate | 2418 / 14979 (16.1%) | 10381 / 149790 (6.9%) | −283.5 | −280.5 | 2.33 |
| TP53 SRX19538274 | U2OS Bone | 404 / 14979 (2.7%) | 166 / 149790 (0.1%) | −281.7 | −278.7 | 24.34 |
| TP53 SRX19538268 | U2OS Bone | 399 / 14979 (2.7%) | 168 / 149790 (0.1%) | −276.2 | −273.3 | 23.75 |
| TP53 SRX19538276 | U2OS Bone | 404 / 14979 (2.7%) | 178 / 149790 (0.1%) | −275.9 | −272.9 | 22.70 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2132 / 14979 (14.2%) | 8651 / 149790 (5.8%) | −274.6 | −271.7 | 2.46 |
| FOXA1 SRX4815198 | MCF-7 Breast | 766 / 14979 (5.1%) | 21591 / 149790 (14.4%) | −272.3 | −269.4 | 0.35 |
| FOS SRX4192880 | MCF 10A Breast | 315 / 14979 (2.1%) | 14090 / 149790 (9.4%) | −271.2 | −268.3 | 0.22 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 644 / 14979 (4.3%) | 848 / 149790 (0.6%) | −268.5 | −265.6 | 7.59 |
| FOXA1 SRX4815197 | MCF-7 Breast | 541 / 14979 (3.6%) | 17738 / 149790 (11.8%) | −262.4 | −259.6 | 0.30 |
| TP53 SRX19538280 | Osteoblasts Bone | 394 / 14979 (2.6%) | 191 / 149790 (0.1%) | −261.0 | −258.2 | 20.63 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1457 / 14979 (9.7%) | 4789 / 149790 (3.2%) | −257.1 | −254.3 | 3.04 |
| CIC SRX13262055 | Astrocytes Neural | 2975 / 14979 (19.9%) | 14874 / 149790 (9.9%) | −256.5 | −253.7 | 2.00 |
| TP53 SRX19538267 | U2OS Bone | 363 / 14979 (2.4%) | 145 / 149790 (0.1%) | −255.1 | −252.3 | 25.03 |
| IRF3 SRX11453858 | Hep G2 Liver | 308 / 14979 (2.1%) | 64 / 149790 (0.0%) | −251.7 | −248.9 | 48.13 |
| FOS SRX150517 | MCF 10A Breast | 349 / 14979 (2.3%) | 14116 / 149790 (9.4%) | −250.8 | −248.0 | 0.25 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 806 / 14979 (5.4%) | 21464 / 149790 (14.3%) | −250.5 | −247.7 | 0.38 |
| JUNB SRX8488088 | SUM 229PE Breast | 410 / 14979 (2.7%) | 15115 / 149790 (10.1%) | −248.4 | −245.6 | 0.27 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 526 / 14979 (3.5%) | 577 / 149790 (0.4%) | −244.6 | −241.8 | 9.12 |
| FOXA1 SRX176862 | MCF-7 Breast | 268 / 14979 (1.8%) | 12439 / 149790 (8.3%) | −244.3 | −241.5 | 0.22 |
| TP53 SRX19538273 | U2OS Bone | 353 / 14979 (2.4%) | 151 / 149790 (0.1%) | −243.1 | −240.4 | 23.38 |
| TP53 SRX19538275 | U2OS Bone | 360 / 14979 (2.4%) | 170 / 149790 (0.1%) | −240.5 | −237.7 | 21.18 |
| FOS SRX150476 | MCF 10A Breast | 375 / 14979 (2.5%) | 14190 / 149790 (9.5%) | −237.8 | −235.0 | 0.26 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 258 / 14979 (1.7%) | 12043 / 149790 (8.0%) | −237.1 | −234.4 | 0.21 |
| TP53 SRX19538281 | Osteoblasts Bone | 410 / 14979 (2.7%) | 293 / 149790 (0.2%) | −235.1 | −232.4 | 13.99 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 379 / 14979 (2.5%) | 224 / 149790 (0.1%) | −234.3 | −231.6 | 16.92 |
| KAT6A SRX20971022 | Fibroblasts Others | 286 / 14979 (1.9%) | 63 / 149790 (0.0%) | −231.2 | −228.4 | 45.40 |
| FOXA1 SRX3931044 | MCF-7 Breast | 515 / 14979 (3.4%) | 16310 / 149790 (10.9%) | −230.7 | −228.0 | 0.32 |
| TP53 SRX19538269 | U2OS Bone | 440 / 14979 (2.9%) | 384 / 149790 (0.3%) | −230.5 | −227.8 | 11.46 |
| FOXA1 SRX176863 | MCF-7 Breast | 256 / 14979 (1.7%) | 11806 / 149790 (7.9%) | −230.1 | −227.4 | 0.22 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 841 / 14979 (5.6%) | 21211 / 149790 (14.2%) | −228.2 | −225.5 | 0.40 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 522 / 14979 (3.5%) | 644 / 149790 (0.4%) | −226.4 | −223.7 | 8.11 |
| RELA SRX2207673 | HUVEC Cardiovascular | 934 / 14979 (6.2%) | 22475 / 149790 (15.0%) | −226.1 | −223.4 | 0.42 |
| TRP47 SRX4548329 | THP-1 Blood | 2535 / 14979 (16.9%) | 12394 / 149790 (8.3%) | −225.8 | −223.1 | 2.05 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 133 / 14979 (0.9%) | 9188 / 149790 (6.1%) | −225.6 | −223.0 | 0.14 |
| GATA3 SRX190239 | MCF-7 Breast | 338 / 14979 (2.3%) | 13136 / 149790 (8.8%) | −224.5 | −221.8 | 0.26 |
| ESR1 SRX7624157 | MCF-7 Breast | 660 / 14979 (4.4%) | 18344 / 149790 (12.2%) | −223.3 | −220.6 | 0.36 |
| Epitope tags SRX10549776 | K-562 Blood | 1351 / 14979 (9.0%) | 4640 / 149790 (3.1%) | −222.6 | −219.9 | 2.91 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 288 / 14979 (1.9%) | 12184 / 149790 (8.1%) | −222.6 | −219.9 | 0.24 |
| SMARCA2 SRX8119677 | MeT-5A Others | 376 / 14979 (2.5%) | 13670 / 149790 (9.1%) | −220.3 | −217.6 | 0.28 |
| ESR1 SRX371478 | MCF-7 Breast | 296 / 14979 (2.0%) | 12231 / 149790 (8.2%) | −219.2 | −216.6 | 0.24 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 591 / 14979 (3.9%) | 17118 / 149790 (11.4%) | −218.4 | −215.8 | 0.35 |
| JUN SRX17561461 | LPS141 Adipocyte | 324 / 14979 (2.2%) | 12698 / 149790 (8.5%) | −218.1 | −215.5 | 0.26 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 259 / 14979 (1.7%) | 11489 / 149790 (7.7%) | −217.3 | −214.7 | 0.23 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 414 / 14979 (2.8%) | 14205 / 149790 (9.5%) | −216.7 | −214.1 | 0.29 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 552 / 14979 (3.7%) | 16436 / 149790 (11.0%) | −216.4 | −213.8 | 0.34 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 592 / 14979 (4.0%) | 17058 / 149790 (11.4%) | −216.1 | −213.5 | 0.35 |
| AR SRX1067071 | LHSAR Prostate | 483 / 14979 (3.2%) | 15315 / 149790 (10.2%) | −215.8 | −213.2 | 0.32 |
| YAP1 SRX5718140 | 293 Kidney | 402 / 14979 (2.7%) | 13967 / 149790 (9.3%) | −215.5 | −212.9 | 0.29 |
| ESR1 SRX4367193 | MCF-7 Breast | 862 / 14979 (5.8%) | 21039 / 149790 (14.0%) | −214.8 | −212.2 | 0.41 |
| FOXA1 SRX1161177 | MCF-7 Breast | 227 / 14979 (1.5%) | 10804 / 149790 (7.2%) | −214.5 | −211.9 | 0.21 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1044 / 14979 (7.0%) | 23601 / 149790 (15.8%) | −214.5 | −211.9 | 0.44 |
| IRF3 SRX11453861 | Hep G2 Liver | 270 / 14979 (1.8%) | 65 / 149790 (0.0%) | −214.5 | −211.9 | 41.54 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1709 / 14979 (11.4%) | 6987 / 149790 (4.7%) | −213.4 | −210.9 | 2.45 |
| SREBF2 SRX5359048 | HCC70 Breast | 1678 / 14979 (11.2%) | 6802 / 149790 (4.5%) | −212.8 | −210.2 | 2.47 |
| GATA3 SRX190194 | SK-N-SH Neural | 601 / 14979 (4.0%) | 17064 / 149790 (11.4%) | −212.2 | −209.7 | 0.35 |
| FOXA1 SRX371482 | MCF-7 Breast | 352 / 14979 (2.3%) | 12994 / 149790 (8.7%) | −211.8 | −209.2 | 0.27 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 419 / 14979 (2.8%) | 14110 / 149790 (9.4%) | −211.1 | −208.5 | 0.30 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 266 / 14979 (1.8%) | 11434 / 149790 (7.6%) | −211.0 | −208.4 | 0.23 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 188 / 14979 (1.3%) | 9925 / 149790 (6.6%) | −210.4 | −207.9 | 0.19 |
| TLE3 SRX4815191 | MCF-7 Breast | 211 / 14979 (1.4%) | 10366 / 149790 (6.9%) | −210.0 | −207.5 | 0.20 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 237 / 14979 (1.6%) | 10865 / 149790 (7.3%) | −209.9 | −207.4 | 0.22 |
| FOS SRX4192879 | MCF 10A Breast | 250 / 14979 (1.7%) | 11088 / 149790 (7.4%) | −209.2 | −206.7 | 0.23 |
| JUNB SRX8488073 | SUM 229PE Breast | 467 / 14979 (3.1%) | 14834 / 149790 (9.9%) | −209.0 | −206.4 | 0.31 |
| FOXA1 SRX371481 | MCF-7 Breast | 249 / 14979 (1.7%) | 11041 / 149790 (7.4%) | −208.3 | −205.8 | 0.23 |
| TP53 SRX19538270 | U2OS Bone | 414 / 14979 (2.8%) | 392 / 149790 (0.3%) | −208.2 | −205.7 | 10.56 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 848 / 14979 (5.7%) | 20575 / 149790 (13.7%) | −207.6 | −205.1 | 0.41 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 638 / 14979 (4.3%) | 17452 / 149790 (11.7%) | −206.9 | −204.4 | 0.37 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 540 / 14979 (3.6%) | 15902 / 149790 (10.6%) | −205.9 | −203.4 | 0.34 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 494 / 14979 (3.3%) | 15153 / 149790 (10.1%) | −205.4 | −202.9 | 0.33 |
| ESR1 SRX371469 | MCF-7 Breast | 250 / 14979 (1.7%) | 10918 / 149790 (7.3%) | −203.6 | −201.1 | 0.23 |
| TCF12 SRX190356 | SK-N-SH Neural | 729 / 14979 (4.9%) | 18669 / 149790 (12.5%) | −202.8 | −200.3 | 0.39 |
| ESR1 SRX7624156 | MCF-7 Breast | 415 / 14979 (2.8%) | 13774 / 149790 (9.2%) | −202.6 | −200.1 | 0.30 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 209 / 14979 (1.4%) | 10107 / 149790 (6.7%) | −202.4 | −199.9 | 0.21 |
| SMARCA4 SRX5212366 | Mel270 Others | 319 / 14979 (2.1%) | 12124 / 149790 (8.1%) | −202.1 | −199.7 | 0.26 |
| AGO2 SRX6783957 | Hep G2 Liver | 1198 / 14979 (8.0%) | 4041 / 149790 (2.7%) | −201.9 | −199.4 | 2.96 |
| FOXA1 SRX371483 | MCF-7 Breast | 282 / 14979 (1.9%) | 11416 / 149790 (7.6%) | −200.6 | −198.1 | 0.25 |
| AR SRX1067070 | LHSAR Prostate | 656 / 14979 (4.4%) | 17493 / 149790 (11.7%) | −200.3 | −197.8 | 0.38 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 202 / 14979 (1.3%) | 9866 / 149790 (6.6%) | −198.7 | −196.2 | 0.20 |
| FOXA1 SRX1161176 | MCF-7 Breast | 228 / 14979 (1.5%) | 10363 / 149790 (6.9%) | −198.6 | −196.1 | 0.22 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 368 / 14979 (2.5%) | 12830 / 149790 (8.6%) | −197.7 | −195.3 | 0.29 |
| CEBPB SRX150632 | HeLa Uterus | 610 / 14979 (4.1%) | 16695 / 149790 (11.1%) | −197.3 | −194.9 | 0.37 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 430 / 14979 (2.9%) | 13835 / 149790 (9.2%) | −196.8 | −194.3 | 0.31 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 220 / 14979 (1.5%) | 10155 / 149790 (6.8%) | −196.6 | −194.2 | 0.22 |
| SMARCA4 SRX5212362 | Mel270 Others | 444 / 14979 (3.0%) | 14053 / 149790 (9.4%) | −196.4 | −194.0 | 0.32 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 781 / 14979 (5.2%) | 19148 / 149790 (12.8%) | −194.9 | −192.5 | 0.41 |
| ESR1 SRX20282961 | MCF-7 Breast | 329 / 14979 (2.2%) | 12064 / 149790 (8.1%) | −194.6 | −192.2 | 0.27 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 202 / 14979 (1.3%) | 9712 / 149790 (6.5%) | −193.3 | −190.8 | 0.21 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 235 / 14979 (1.6%) | 10335 / 149790 (6.9%) | −193.2 | −190.8 | 0.23 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 383 / 14979 (2.6%) | 12937 / 149790 (8.6%) | −193.0 | −190.6 | 0.30 |
| SMARCA4 SRX5212357 | Mel270 Others | 369 / 14979 (2.5%) | 12681 / 149790 (8.5%) | −192.3 | −189.9 | 0.29 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 515 / 14979 (3.4%) | 15050 / 149790 (10.0%) | −192.2 | −189.8 | 0.34 |
| NKX2-1 SRX2164786 | A549 Lung | 427 / 14979 (2.9%) | 13635 / 149790 (9.1%) | −192.2 | −189.7 | 0.31 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 234 / 14979 (1.6%) | 10280 / 149790 (6.9%) | −192.0 | −189.6 | 0.23 |
| ESR1 SRX371479 | MCF-7 Breast | 225 / 14979 (1.5%) | 10113 / 149790 (6.8%) | −192.0 | −189.5 | 0.22 |
| FOXA1 SRX1161173 | MCF-7 Breast | 187 / 14979 (1.2%) | 9374 / 149790 (6.3%) | −191.8 | −189.4 | 0.20 |
| JUN SRX4192884 | MCF 10A Breast | 179 / 14979 (1.2%) | 9216 / 149790 (6.2%) | −191.7 | −189.3 | 0.19 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 510 / 14979 (3.4%) | 14948 / 149790 (10.0%) | −191.5 | −189.1 | 0.34 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 625 / 14979 (4.2%) | 1235 / 149790 (0.8%) | −191.3 | −188.9 | 5.06 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1578 / 14979 (10.5%) | 6543 / 149790 (4.4%) | −191.1 | −188.7 | 2.41 |
| RUNX1 SRX2014504 | Jurkat Blood | 2272 / 14979 (15.2%) | 11331 / 149790 (7.6%) | −190.6 | −188.2 | 2.01 |
| ESR1 SRX371471 | ZR-75-1 Breast | 272 / 14979 (1.8%) | 10922 / 149790 (7.3%) | −190.2 | −187.8 | 0.25 |
| JUNB SRX8488089 | SUM 229PE Breast | 230 / 14979 (1.5%) | 10153 / 149790 (6.8%) | −190.1 | −187.8 | 0.23 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1812 / 14979 (12.1%) | 8124 / 149790 (5.4%) | −189.6 | −187.2 | 2.23 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1738 / 14979 (11.6%) | 7651 / 149790 (5.1%) | −188.3 | −185.9 | 2.27 |
| AGO2 SRX6783958 | Hep G2 Liver | 1151 / 14979 (7.7%) | 3960 / 149790 (2.6%) | −188.1 | −185.7 | 2.91 |
| JUNB SRX8488074 | SUM 229PE Breast | 335 / 14979 (2.2%) | 11947 / 149790 (8.0%) | −187.5 | −185.1 | 0.28 |
| SMARCA4 SRX5212371 | Mel270 Others | 367 / 14979 (2.5%) | 12474 / 149790 (8.3%) | −186.9 | −184.6 | 0.29 |
| JUN SRX883584 | MDA-MB-231 Breast | 410 / 14979 (2.7%) | 13185 / 149790 (8.8%) | −186.9 | −184.6 | 0.31 |
| FOXA1 SRX1161175 | MCF-7 Breast | 178 / 14979 (1.2%) | 9056 / 149790 (6.0%) | −186.9 | −184.6 | 0.20 |
| VGLL1 SRX24602130 | BT-20 Breast | 256 / 14979 (1.7%) | 10523 / 149790 (7.0%) | −186.6 | −184.2 | 0.24 |
| JUNB SRX4192882 | MCF 10A Breast | 173 / 14979 (1.2%) | 8943 / 149790 (6.0%) | −186.4 | −184.0 | 0.19 |
| MITF SRX1555436 | 501A Epidermis | 1859 / 14979 (12.4%) | 8513 / 149790 (5.7%) | −186.3 | −183.9 | 2.18 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 342 / 14979 (2.3%) | 12016 / 149790 (8.0%) | −185.9 | −183.6 | 0.28 |
| STAT3 SRX2020842 | HCC70 Breast | 482 / 14979 (3.2%) | 14302 / 149790 (9.5%) | −185.6 | −183.2 | 0.34 |
| SS18 SRX3468047 | Fibroblasts Others | 699 / 14979 (4.7%) | 17604 / 149790 (11.8%) | −185.4 | −183.1 | 0.40 |
| ARID1A SRX5089376 | MCF-7 Breast | 212 / 14979 (1.4%) | 9668 / 149790 (6.5%) | −185.3 | −182.9 | 0.22 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 181 / 14979 (1.2%) | 9042 / 149790 (6.0%) | −184.4 | −182.0 | 0.20 |
| ESR1 SRX20282960 | MCF-7 Breast | 309 / 14979 (2.1%) | 11384 / 149790 (7.6%) | −183.9 | −181.6 | 0.27 |
| ESR1 SRX371470 | ZR-75-1 Breast | 232 / 14979 (1.5%) | 9983 / 149790 (6.7%) | −183.2 | −180.8 | 0.23 |
| FOXA1 SRX11222441 | MCF-7 Breast | 181 / 14979 (1.2%) | 9003 / 149790 (6.0%) | −182.9 | −180.6 | 0.20 |
| JUNB SRX10119386 | MCF 10A Breast | 210 / 14979 (1.4%) | 9559 / 149790 (6.4%) | −182.8 | −180.5 | 0.22 |
| PRRX1 SRX15235713 | Hs 578T Breast | 311 / 14979 (2.1%) | 11387 / 149790 (7.6%) | −182.8 | −180.4 | 0.27 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1818 / 14979 (12.1%) | 8315 / 149790 (5.6%) | −182.3 | −180.0 | 2.19 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 224 / 14979 (1.5%) | 9801 / 149790 (6.5%) | −182.1 | −179.8 | 0.23 |
| ESR1 SRX176860 | MCF-7 Breast | 465 / 14979 (3.1%) | 13916 / 149790 (9.3%) | −182.1 | −179.8 | 0.33 |
| KAT7 SRX101303 | RKO Digestive tract | 1244 / 14979 (8.3%) | 4604 / 149790 (3.1%) | −181.7 | −179.3 | 2.70 |
| ESR1 SRX194572 | MCF-7 Breast | 149 / 14979 (1.0%) | 8327 / 149790 (5.6%) | −181.6 | −179.3 | 0.18 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 231 / 14979 (1.5%) | 9916 / 149790 (6.6%) | −181.6 | −179.3 | 0.23 |
| BRD1 SRX286203 | RKO Digestive tract | 1096 / 14979 (7.3%) | 3737 / 149790 (2.5%) | −181.2 | −178.9 | 2.93 |
| BRD4 SRX736204 | 90-8TL Neural | 883 / 14979 (5.9%) | 2565 / 149790 (1.7%) | −180.8 | −178.5 | 3.44 |
| FOXA1 SRX1787653 | MCF-7 Breast | 199 / 14979 (1.3%) | 9285 / 149790 (6.2%) | −180.7 | −178.4 | 0.21 |
| ESR1 SRX371476 | MCF-7 Breast | 182 / 14979 (1.2%) | 8956 / 149790 (6.0%) | −180.6 | −178.3 | 0.20 |
| ESR1 SRX20282939 | MCF-7 Breast | 312 / 14979 (2.1%) | 11321 / 149790 (7.6%) | −180.2 | −177.9 | 0.28 |
| ESR1 SRX371468 | MCF-7 Breast | 154 / 14979 (1.0%) | 8372 / 149790 (5.6%) | −179.7 | −177.4 | 0.18 |
| FOXA1 SRX1161174 | MCF-7 Breast | 272 / 14979 (1.8%) | 10598 / 149790 (7.1%) | −179.5 | −177.3 | 0.26 |
| FOXA1 SRX11222442 | MCF-7 Breast | 152 / 14979 (1.0%) | 8318 / 149790 (5.6%) | −179.2 | −176.9 | 0.18 |
| TP53 SRX19538282 | Osteoblasts Bone | 343 / 14979 (2.3%) | 301 / 149790 (0.2%) | −179.2 | −176.9 | 11.40 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 375 / 14979 (2.5%) | 12349 / 149790 (8.2%) | −178.9 | −176.6 | 0.30 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 224 / 14979 (1.5%) | 9706 / 149790 (6.5%) | −178.8 | −176.6 | 0.23 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 602 / 14979 (4.0%) | 1230 / 149790 (0.8%) | −178.7 | −176.5 | 4.89 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 236 / 14979 (1.6%) | 9917 / 149790 (6.6%) | −178.6 | −176.3 | 0.24 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 234 / 14979 (1.6%) | 9878 / 149790 (6.6%) | −178.4 | −176.1 | 0.24 |
| GATA3 SRX5057632 | MCF-7 Breast | 159 / 14979 (1.1%) | 8430 / 149790 (5.6%) | −178.1 | −175.9 | 0.19 |
| EP300 SRX150579 | HeLa Uterus | 147 / 14979 (1.0%) | 8184 / 149790 (5.5%) | −178.1 | −175.8 | 0.18 |
| BMI1 SRX7196721 | SF8628 Neural | 1626 / 14979 (10.9%) | 7109 / 149790 (4.7%) | −177.9 | −175.6 | 2.29 |
| FOXA1 SRX100454 | T-47D Breast | 356 / 14979 (2.4%) | 11960 / 149790 (8.0%) | −176.7 | −174.5 | 0.30 |
| ESR1 SRX176861 | MCF-7 Breast | 477 / 14979 (3.2%) | 13916 / 149790 (9.3%) | −176.5 | −174.2 | 0.34 |
| GATA3 SRX176864 | MCF-7 Breast | 186 / 14979 (1.2%) | 8905 / 149790 (5.9%) | −176.1 | −173.9 | 0.21 |
| FOXA2 SRX3230382 | Hep G2 Liver | 378 / 14979 (2.5%) | 12303 / 149790 (8.2%) | −175.9 | −173.7 | 0.31 |
| AR SRX1067067 | LHSAR Prostate | 474 / 14979 (3.2%) | 13849 / 149790 (9.2%) | −175.9 | −173.6 | 0.34 |
| AR SRX10820653 | LNCAP Prostate | 295 / 14979 (2.0%) | 192 / 149790 (0.1%) | −175.7 | −173.5 | 15.36 |
| FOXA1 SRX371480 | MCF-7 Breast | 168 / 14979 (1.1%) | 8535 / 149790 (5.7%) | −175.5 | −173.2 | 0.20 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 264 / 14979 (1.8%) | 10326 / 149790 (6.9%) | −175.3 | −173.1 | 0.26 |
| TP53 SRX19538271 | U2OS Bone | 569 / 14979 (3.8%) | 1117 / 149790 (0.7%) | −175.0 | −172.8 | 5.09 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 846 / 14979 (5.6%) | 19329 / 149790 (12.9%) | −174.9 | −172.6 | 0.44 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 182 / 14979 (1.2%) | 8780 / 149790 (5.9%) | −174.5 | −172.2 | 0.21 |
| WWTR1 SRX10119367 | MCF 10A Breast | 306 / 14979 (2.0%) | 11009 / 149790 (7.3%) | −173.5 | −171.2 | 0.28 |
| PBX3 SRX190343 | SK-N-SH Neural | 598 / 14979 (4.0%) | 15662 / 149790 (10.5%) | −173.1 | −170.8 | 0.38 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1702 / 14979 (11.4%) | 7720 / 149790 (5.2%) | −172.9 | −170.7 | 2.20 |
| BRPF3 SRX796086 | RKO Digestive tract | 1317 / 14979 (8.8%) | 5206 / 149790 (3.5%) | −172.3 | −170.1 | 2.53 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 520 / 14979 (3.5%) | 14447 / 149790 (9.6%) | −172.3 | −170.1 | 0.36 |
| BRPF3 SRX796085 | RKO Digestive tract | 991 / 14979 (6.6%) | 3264 / 149790 (2.2%) | −171.9 | −169.6 | 3.04 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 203 / 14979 (1.4%) | 9099 / 149790 (6.1%) | −171.8 | −169.5 | 0.22 |
| STAT3 SRX150630 | MCF 10A Breast | 236 / 14979 (1.6%) | 9703 / 149790 (6.5%) | −171.4 | −169.2 | 0.24 |
| ESR1 SRX1531791 | MCF-7 Breast | 271 / 14979 (1.8%) | 10326 / 149790 (6.9%) | −171.2 | −168.9 | 0.26 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1474 / 14979 (9.8%) | 6247 / 149790 (4.2%) | −170.6 | −168.3 | 2.36 |
| MethylCap SRX014767 | NB-4 Blood | 1594 / 14979 (10.6%) | 7050 / 149790 (4.7%) | −170.1 | −167.9 | 2.26 |
| STAT3 SRX150479 | MCF 10A Breast | 241 / 14979 (1.6%) | 9753 / 149790 (6.5%) | −170.0 | −167.8 | 0.25 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 665 / 14979 (4.4%) | 16544 / 149790 (11.0%) | −170.0 | −167.8 | 0.40 |
| ESR1 SRX194569 | MCF-7 Breast | 297 / 14979 (2.0%) | 10731 / 149790 (7.2%) | −169.7 | −167.5 | 0.28 |
| JUN SRX2355072 | HAEC Cardiovascular | 364 / 14979 (2.4%) | 11860 / 149790 (7.9%) | −169.4 | −167.2 | 0.31 |
| JUND SRX150408 | HeLa Uterus | 223 / 14979 (1.5%) | 9405 / 149790 (6.3%) | −169.4 | −167.2 | 0.24 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 494 / 14979 (3.3%) | 13931 / 149790 (9.3%) | −169.2 | −167.0 | 0.35 |
| YAP1 SRX10119364 | MCF 10A Breast | 209 / 14979 (1.4%) | 9121 / 149790 (6.1%) | −168.6 | −166.4 | 0.23 |
| STAT3 SRX150536 | MCF 10A Breast | 295 / 14979 (2.0%) | 10665 / 149790 (7.1%) | −168.6 | −166.4 | 0.28 |
| FOXA1 SRX3923514 | MCF-7 Breast | 283 / 14979 (1.9%) | 10452 / 149790 (7.0%) | −168.5 | −166.3 | 0.27 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 250 / 14979 (1.7%) | 115 / 149790 (0.1%) | −168.4 | −166.2 | 21.74 |
| ARID1A SRX5089379 | MCF-7 Breast | 272 / 14979 (1.8%) | 10253 / 149790 (6.8%) | −168.3 | −166.1 | 0.27 |
| EP300 SRX2194265 | SUM 159PT Breast | 443 / 14979 (3.0%) | 13092 / 149790 (8.7%) | −168.0 | −165.8 | 0.34 |
| STAT5B SRX831881 | CD8+ T cells Blood | 251 / 14979 (1.7%) | 118 / 149790 (0.1%) | −167.9 | −165.7 | 21.27 |
| ESR1 SRX371467 | MCF-7 Breast | 302 / 14979 (2.0%) | 10755 / 149790 (7.2%) | −167.6 | −165.4 | 0.28 |
| BRPF3 SRX796084 | RKO Digestive tract | 1355 / 14979 (9.0%) | 5536 / 149790 (3.7%) | −167.2 | −165.0 | 2.45 |
| RAC1 SRX10365541 | MCF-7 Breast | 129 / 14979 (0.9%) | 7500 / 149790 (5.0%) | −167.1 | −164.9 | 0.17 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 378 / 14979 (2.5%) | 11990 / 149790 (8.0%) | −166.5 | −164.3 | 0.32 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1657 / 14979 (11.1%) | 7556 / 149790 (5.0%) | −166.3 | −164.1 | 2.19 |
| MECOM SRX23677896 | HNT-34 Blood | 1946 / 14979 (13.0%) | 9576 / 149790 (6.4%) | −166.2 | −164.0 | 2.03 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 408 / 14979 (2.7%) | 12465 / 149790 (8.3%) | −166.1 | −163.9 | 0.33 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 276 / 14979 (1.8%) | 10246 / 149790 (6.8%) | −165.9 | −163.7 | 0.27 |
| FOXA2 SRX100448 | Hep G2 Liver | 315 / 14979 (2.1%) | 10912 / 149790 (7.3%) | −165.7 | −163.5 | 0.29 |
| ESR1 SRX371475 | BT-474 Breast | 115 / 14979 (0.8%) | 7155 / 149790 (4.8%) | −165.4 | −163.2 | 0.16 |
| FOXA1 SRX100506 | Hep G2 Liver | 390 / 14979 (2.6%) | 12148 / 149790 (8.1%) | −165.3 | −163.1 | 0.32 |
| AR SRX1067066 | LHSAR Prostate | 628 / 14979 (4.2%) | 15827 / 149790 (10.6%) | −165.3 | −163.1 | 0.40 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 158 / 14979 (1.1%) | 8034 / 149790 (5.4%) | −165.1 | −163.0 | 0.20 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1656 / 14979 (11.1%) | 7571 / 149790 (5.1%) | −165.1 | −162.9 | 2.19 |
| EP300 SRX2194266 | SUM 159PT Breast | 500 / 14979 (3.3%) | 13883 / 149790 (9.3%) | −165.1 | −162.9 | 0.36 |
| FOSL2 SRX190296 | SK-N-SH Neural | 375 / 14979 (2.5%) | 11893 / 149790 (7.9%) | −165.0 | −162.8 | 0.32 |
| MECOM SRX23677885 | HNT-34 Blood | 1620 / 14979 (10.8%) | 7331 / 149790 (4.9%) | −164.9 | −162.8 | 2.21 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1588 / 14979 (10.6%) | 7115 / 149790 (4.7%) | −164.8 | −162.7 | 2.23 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 187 / 14979 (1.2%) | 8588 / 149790 (5.7%) | −164.6 | −162.5 | 0.22 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 513 / 14979 (3.4%) | 14070 / 149790 (9.4%) | −164.6 | −162.5 | 0.36 |
| RAC1 SRX10365543 | MCF-7 Breast | 133 / 14979 (0.9%) | 7513 / 149790 (5.0%) | −164.6 | −162.5 | 0.18 |
| DAXX SRX1021630 | PC-3 Prostate | 278 / 14979 (1.9%) | 10243 / 149790 (6.8%) | −164.6 | −162.5 | 0.27 |
| AR SRX9469988 | LAPC-4 Prostate | 383 / 14979 (2.6%) | 12007 / 149790 (8.0%) | −164.4 | −162.3 | 0.32 |
| ESR1 SRX20282954 | MCF-7 Breast | 320 / 14979 (2.1%) | 10953 / 149790 (7.3%) | −164.2 | −162.1 | 0.29 |
| FOXA1 SRX11222437 | MCF-7 Breast | 195 / 14979 (1.3%) | 8719 / 149790 (5.8%) | −163.9 | −161.8 | 0.22 |
| JUND SRX190357 | SK-N-SH Neural | 355 / 14979 (2.4%) | 11524 / 149790 (7.7%) | −163.8 | −161.6 | 0.31 |
| ESR1 SRX10365536 | MCF-7 Breast | 134 / 14979 (0.9%) | 7507 / 149790 (5.0%) | −163.7 | −161.5 | 0.18 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 487 / 14979 (3.3%) | 862 / 149790 (0.6%) | −163.4 | −161.3 | 5.65 |
| NR2F2 SRX190293 | MCF-7 Breast | 302 / 14979 (2.0%) | 10611 / 149790 (7.1%) | −163.2 | −161.1 | 0.28 |
| FOS SRX3322636 | MCF-7 Breast | 159 / 14979 (1.1%) | 8000 / 149790 (5.3%) | −163.1 | −161.0 | 0.20 |
| JUN SRX6582172 | Fibroblasts Others | 374 / 14979 (2.5%) | 11806 / 149790 (7.9%) | −162.8 | −160.7 | 0.32 |
| TEAD1 SRX3401272 | MCF-7 Breast | 201 / 14979 (1.3%) | 8793 / 149790 (5.9%) | −162.7 | −160.6 | 0.23 |
| FOS SRX070879 | HUVEC Cardiovascular | 295 / 14979 (2.0%) | 10473 / 149790 (7.0%) | −162.6 | −160.5 | 0.28 |
| ESR1 SRX2943591 | MCF-7 Breast | 190 / 14979 (1.3%) | 8576 / 149790 (5.7%) | −162.4 | −160.3 | 0.22 |
| MECOM SRX23677897 | HNT-34 Blood | 1875 / 14979 (12.5%) | 9171 / 149790 (6.1%) | −161.9 | −159.8 | 2.04 |
| FOSL2 SRX190204 | A549 Lung | 269 / 14979 (1.8%) | 9999 / 149790 (6.7%) | −161.9 | −159.8 | 0.27 |
| FOXL2 SRX6957431 | KGN Gonad | 698 / 14979 (4.7%) | 16708 / 149790 (11.2%) | −161.5 | −159.4 | 0.42 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 505 / 14979 (3.4%) | 13833 / 149790 (9.2%) | −161.5 | −159.3 | 0.37 |
| TP53 SRX396254 | Fibroblasts Others | 817 / 14979 (5.5%) | 2446 / 149790 (1.6%) | −160.7 | −158.6 | 3.34 |
| NR3C1 SRX17639412 | A549 Lung | 314 / 14979 (2.1%) | 10733 / 149790 (7.2%) | −160.6 | −158.5 | 0.29 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 270 / 14979 (1.8%) | 9975 / 149790 (6.7%) | −160.5 | −158.4 | 0.27 |
| FOXA1 SRX3931043 | MCF-7 Breast | 290 / 14979 (1.9%) | 10314 / 149790 (6.9%) | −160.3 | −158.2 | 0.28 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 308 / 14979 (2.1%) | 10620 / 149790 (7.1%) | −160.2 | −158.1 | 0.29 |
| ESR1 SRX20282972 | MCF-7 Breast | 337 / 14979 (2.2%) | 11102 / 149790 (7.4%) | −160.0 | −157.9 | 0.30 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 217 / 14979 (1.4%) | 9008 / 149790 (6.0%) | −160.0 | −157.9 | 0.24 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 258 / 14979 (1.7%) | 9743 / 149790 (6.5%) | −159.9 | −157.8 | 0.26 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 442 / 14979 (3.0%) | 12793 / 149790 (8.5%) | −159.7 | −157.6 | 0.35 |
| FOXA1 SRX3931054 | MCF-7 Breast | 264 / 14979 (1.8%) | 9842 / 149790 (6.6%) | −159.6 | −157.5 | 0.27 |
| ARID5B SRX3230377 | Hep G2 Liver | 774 / 14979 (5.2%) | 17721 / 149790 (11.8%) | −159.6 | −157.5 | 0.44 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 372 / 14979 (2.5%) | 11648 / 149790 (7.8%) | −159.1 | −157.0 | 0.32 |
| FOXA1 SRX1787652 | MCF-7 Breast | 159 / 14979 (1.1%) | 7878 / 149790 (5.3%) | −159.0 | −156.9 | 0.20 |
| WWTR1 SRX10119378 | MCF 10A Breast | 300 / 14979 (2.0%) | 10434 / 149790 (7.0%) | −158.6 | −156.5 | 0.29 |
| FOXA1 SRX3931055 | MCF-7 Breast | 237 / 14979 (1.6%) | 9328 / 149790 (6.2%) | −158.5 | −156.4 | 0.25 |
| JUNB SRX10119383 | MCF 10A Breast | 175 / 14979 (1.2%) | 8174 / 149790 (5.5%) | −158.5 | −156.4 | 0.21 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 194 / 14979 (1.3%) | 8527 / 149790 (5.7%) | −158.2 | −156.1 | 0.23 |
| ESR1 SRX371477 | MCF-7 Breast | 127 / 14979 (0.8%) | 7204 / 149790 (4.8%) | −157.9 | −155.8 | 0.18 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 303 / 14979 (2.0%) | 10450 / 149790 (7.0%) | −157.6 | −155.6 | 0.29 |
| JUN SRX6582171 | GM07492 Others | 586 / 14979 (3.9%) | 14920 / 149790 (10.0%) | −157.6 | −155.5 | 0.39 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 119 / 14979 (0.8%) | 7023 / 149790 (4.7%) | −157.5 | −155.4 | 0.17 |
| RELA SRX5938177 | FaDu Others | 261 / 14979 (1.7%) | 9717 / 149790 (6.5%) | −157.4 | −155.3 | 0.27 |
| TLE3 SRX4815192 | MCF-7 Breast | 261 / 14979 (1.7%) | 9721 / 149790 (6.5%) | −157.4 | −155.3 | 0.27 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 260 / 14979 (1.7%) | 9700 / 149790 (6.5%) | −157.3 | −155.2 | 0.27 |
| GATA3 SRX5457550 | MCF-7 Breast | 335 / 14979 (2.2%) | 10978 / 149790 (7.3%) | −157.2 | −155.1 | 0.31 |
| EP300 SRX2671813 | Fibroblasts Others | 228 / 14979 (1.5%) | 9106 / 149790 (6.1%) | −156.5 | −154.4 | 0.25 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 333 / 14979 (2.2%) | 10908 / 149790 (7.3%) | −156.1 | −154.0 | 0.31 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 164 / 14979 (1.1%) | 7889 / 149790 (5.3%) | −156.0 | −153.9 | 0.21 |
| FOXA1 SRX190181 | A549 Lung | 197 / 14979 (1.3%) | 8514 / 149790 (5.7%) | −155.8 | −153.7 | 0.23 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 384 / 14979 (2.6%) | 11720 / 149790 (7.8%) | −155.4 | −153.3 | 0.33 |
| ESR1 SRX371474 | BT-474 Breast | 115 / 14979 (0.8%) | 6879 / 149790 (4.6%) | −155.4 | −153.3 | 0.17 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 356 / 14979 (2.4%) | 11255 / 149790 (7.5%) | −155.1 | −153.0 | 0.32 |
| FOS SRX150664 | HUVEC Cardiovascular | 393 / 14979 (2.6%) | 11854 / 149790 (7.9%) | −155.0 | −153.0 | 0.33 |
| MECOM SRX23677884 | HNT-34 Blood | 1578 / 14979 (10.5%) | 7257 / 149790 (4.8%) | −155.0 | −152.9 | 2.17 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1707 / 14979 (11.4%) | 8161 / 149790 (5.4%) | −154.5 | −152.4 | 2.09 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 196 / 14979 (1.3%) | 8458 / 149790 (5.6%) | −154.5 | −152.4 | 0.23 |
| FOXA1 SRX1447317 | MCF-7 Breast | 177 / 14979 (1.2%) | 8096 / 149790 (5.4%) | −154.4 | −152.4 | 0.22 |
| ESR1 SRX4367192 | MCF-7 Breast | 642 / 14979 (4.3%) | 15625 / 149790 (10.4%) | −154.3 | −152.3 | 0.41 |
| JUNB SRX10119384 | MCF 10A Breast | 156 / 14979 (1.0%) | 7680 / 149790 (5.1%) | −154.2 | −152.2 | 0.20 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 533 / 14979 (3.6%) | 13990 / 149790 (9.3%) | −153.9 | −151.8 | 0.38 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 778 / 14979 (5.2%) | 17543 / 149790 (11.7%) | −153.6 | −151.5 | 0.44 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 271 / 14979 (1.8%) | 9770 / 149790 (6.5%) | −153.4 | −151.4 | 0.28 |
| ESR1 SRX2943589 | MCF-7 Breast | 136 / 14979 (0.9%) | 7258 / 149790 (4.8%) | −153.4 | −151.3 | 0.19 |
| FOXA1 SRX1161203 | T-47D Breast | 198 / 14979 (1.3%) | 8457 / 149790 (5.6%) | −153.3 | −151.3 | 0.23 |
| RNF2 SRX18954719 | SCC-25 Others | 411 / 14979 (2.7%) | 12082 / 149790 (8.1%) | −153.3 | −151.2 | 0.34 |
| PGR SRX1012655 | MCF-7 Breast | 177 / 14979 (1.2%) | 8055 / 149790 (5.4%) | −153.1 | −151.0 | 0.22 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 274 / 14979 (1.8%) | 9793 / 149790 (6.5%) | −152.6 | −150.5 | 0.28 |
| RORC SRX5359052 | HCC70 Breast | 1193 / 14979 (8.0%) | 4768 / 149790 (3.2%) | −152.5 | −150.5 | 2.50 |
| GATAD2A SRX2636506 | Hep G2 Liver | 392 / 14979 (2.6%) | 11742 / 149790 (7.8%) | −152.3 | −150.2 | 0.33 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 238 / 14979 (1.6%) | 9148 / 149790 (6.1%) | −152.2 | −150.2 | 0.26 |
| FOXA1 SRX100477 | Hep G2 Liver | 352 / 14979 (2.3%) | 11073 / 149790 (7.4%) | −151.6 | −149.6 | 0.32 |
| FOXA1 SRX028634 | MCF-7 Breast | 133 / 14979 (0.9%) | 7144 / 149790 (4.8%) | −151.6 | −149.5 | 0.19 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 407 / 14979 (2.7%) | 11952 / 149790 (8.0%) | −151.3 | −149.3 | 0.34 |
| MethylCap SRX014766 | NB-4 Blood | 1408 / 14979 (9.4%) | 6190 / 149790 (4.1%) | −151.1 | −149.1 | 2.27 |
| FOXA1 SRX190282 | A549 Lung | 197 / 14979 (1.3%) | 8365 / 149790 (5.6%) | −151.0 | −148.9 | 0.24 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 243 / 14979 (1.6%) | 9197 / 149790 (6.1%) | −150.9 | −148.9 | 0.26 |
| CEBPA SRX2630241 | Hep G2 Liver | 373 / 14979 (2.5%) | 11391 / 149790 (7.6%) | −150.9 | −148.9 | 0.33 |
| SP1 SRX190358 | HCT 116 Digestive tract | 472 / 14979 (3.2%) | 12934 / 149790 (8.6%) | −150.4 | −148.4 | 0.36 |
| GATA3 SRX6712581 | MCF-7 Breast | 240 / 14979 (1.6%) | 9128 / 149790 (6.1%) | −150.3 | −148.3 | 0.26 |
| RORC SRX5359053 | HCC70 Breast | 1150 / 14979 (7.7%) | 4543 / 149790 (3.0%) | −149.9 | −147.9 | 2.53 |
| FOXA1 SRX3923517 | MCF-7 Breast | 206 / 14979 (1.4%) | 8493 / 149790 (5.7%) | −149.7 | −147.7 | 0.24 |
| MEAF6 DRX234811 | 293 Kidney | 1482 / 14979 (9.9%) | 6722 / 149790 (4.5%) | −149.3 | −147.3 | 2.20 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 253 / 14979 (1.7%) | 9318 / 149790 (6.2%) | −149.1 | −147.1 | 0.27 |
| FOXA1 SRX1787655 | MCF-7 Breast | 134 / 14979 (0.9%) | 7092 / 149790 (4.7%) | −149.1 | −147.1 | 0.19 |
| TET2 SRX1427029 | 293 Kidney | 1174 / 14979 (7.8%) | 4709 / 149790 (3.1%) | −149.0 | −147.0 | 2.49 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 118 / 14979 (0.8%) | 6759 / 149790 (4.5%) | −148.8 | −146.8 | 0.17 |
| FOXA1 SRX1787651 | MCF-7 Breast | 160 / 14979 (1.1%) | 7602 / 149790 (5.1%) | −148.8 | −146.8 | 0.21 |
| ARID5B SRX10475139 | Hep G2 Liver | 332 / 14979 (2.2%) | 10647 / 149790 (7.1%) | −148.7 | −146.7 | 0.31 |
| FOXA1 SRX15430999 | T-47D Breast | 342 / 14979 (2.3%) | 10806 / 149790 (7.2%) | −148.5 | −146.5 | 0.32 |
| FOXA1 SRX5323843 | MCF-7 Breast | 142 / 14979 (0.9%) | 7231 / 149790 (4.8%) | −148.3 | −146.3 | 0.20 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 482 / 14979 (3.2%) | 13006 / 149790 (8.7%) | −148.1 | −146.1 | 0.37 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 396 / 14979 (2.6%) | 11650 / 149790 (7.8%) | −147.7 | −145.7 | 0.34 |
| SP1 SRX190269 | A549 Lung | 452 / 14979 (3.0%) | 12527 / 149790 (8.4%) | −147.6 | −145.6 | 0.36 |
| ESR1 SRX10365535 | MCF-7 Breast | 249 / 14979 (1.7%) | 9198 / 149790 (6.1%) | −147.5 | −145.5 | 0.27 |
| AR SRX9109110 | MDA-MB-453 Breast | 596 / 14979 (4.0%) | 14690 / 149790 (9.8%) | −147.4 | −145.4 | 0.41 |
| SOX13 SRX2636248 | Hep G2 Liver | 429 / 14979 (2.9%) | 12159 / 149790 (8.1%) | −147.4 | −145.4 | 0.35 |
| ESR1 SRX2881002 | MCF-7 Breast | 292 / 14979 (1.9%) | 9934 / 149790 (6.6%) | −147.3 | −145.3 | 0.29 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 462 / 14979 (3.1%) | 12669 / 149790 (8.5%) | −147.2 | −145.2 | 0.36 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 480 / 14979 (3.2%) | 12941 / 149790 (8.6%) | −147.1 | −145.1 | 0.37 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1832 / 14979 (12.2%) | 9225 / 149790 (6.2%) | −147.1 | −145.1 | 1.99 |
| JUN SRX2355073 | HAEC Cardiovascular | 386 / 14979 (2.6%) | 11471 / 149790 (7.7%) | −147.0 | −145.1 | 0.34 |
| NR3C1 SRX10976921 | A549 Lung | 201 / 14979 (1.3%) | 8324 / 149790 (5.6%) | −147.0 | −145.0 | 0.24 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 443 / 14979 (3.0%) | 12363 / 149790 (8.3%) | −146.9 | −144.9 | 0.36 |
| ESR1 SRX20282940 | MCF-7 Breast | 346 / 14979 (2.3%) | 10814 / 149790 (7.2%) | −146.8 | −144.8 | 0.32 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 511 / 14979 (3.4%) | 13400 / 149790 (8.9%) | −146.7 | −144.7 | 0.38 |
| ESR1 SRX20282955 | MCF-7 Breast | 339 / 14979 (2.3%) | 10685 / 149790 (7.1%) | −146.3 | −144.4 | 0.32 |
| HMG20A SRX2630163 | Hep G2 Liver | 159 / 14979 (1.1%) | 7505 / 149790 (5.0%) | −146.1 | −144.1 | 0.21 |
| ARID1A SRX5089391 | MCF-7 Breast | 159 / 14979 (1.1%) | 7500 / 149790 (5.0%) | −146.0 | −144.0 | 0.21 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 134 / 14979 (0.9%) | 7003 / 149790 (4.7%) | −145.9 | −143.9 | 0.19 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 492 / 14979 (3.3%) | 13082 / 149790 (8.7%) | −145.9 | −143.9 | 0.38 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 248 / 14979 (1.7%) | 9126 / 149790 (6.1%) | −145.8 | −143.8 | 0.27 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 196 / 14979 (1.3%) | 8190 / 149790 (5.5%) | −145.7 | −143.8 | 0.24 |
| ESR1 SRX20282973 | MCF-7 Breast | 386 / 14979 (2.6%) | 11421 / 149790 (7.6%) | −145.7 | −143.7 | 0.34 |
| ESR1 SRX20282946 | MCF-7 Breast | 178 / 14979 (1.2%) | 7850 / 149790 (5.2%) | −145.6 | −143.7 | 0.23 |
| EP300 SRX176885 | MCF-7 Breast | 145 / 14979 (1.0%) | 7215 / 149790 (4.8%) | −145.6 | −143.6 | 0.20 |
| EP300 SRX100540 | SK-N-SH Neural | 456 / 14979 (3.0%) | 12508 / 149790 (8.4%) | −145.3 | −143.3 | 0.36 |
| TLE3 SRX4815194 | SUM 149PT Breast | 225 / 14979 (1.5%) | 8701 / 149790 (5.8%) | −145.2 | −143.3 | 0.26 |
| ESR1 SRX10365532 | MCF-7 Breast | 159 / 14979 (1.1%) | 7478 / 149790 (5.0%) | −145.2 | −143.2 | 0.21 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 314 / 14979 (2.1%) | 10214 / 149790 (6.8%) | −144.6 | −142.6 | 0.31 |
| ESR1 SRX330067 | MCF-7 Breast | 281 / 14979 (1.9%) | 9655 / 149790 (6.4%) | −144.5 | −142.5 | 0.29 |
| FOXA1 SRX11222438 | MCF-7 Breast | 157 / 14979 (1.0%) | 7416 / 149790 (5.0%) | −144.5 | −142.5 | 0.21 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 200 / 14979 (1.3%) | 8224 / 149790 (5.5%) | −144.4 | −142.4 | 0.24 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 301 / 14979 (2.0%) | 9980 / 149790 (6.7%) | −144.2 | −142.2 | 0.30 |
| PROX1 SRX3230397 | Hep G2 Liver | 216 / 14979 (1.4%) | 8502 / 149790 (5.7%) | −144.0 | −142.0 | 0.25 |
| AR SRX10820651 | LNCAP Prostate | 295 / 14979 (2.0%) | 296 / 149790 (0.2%) | −143.9 | −142.0 | 9.97 |
| ARID1A SRX5089385 | MCF-7 Breast | 227 / 14979 (1.5%) | 8687 / 149790 (5.8%) | −143.6 | −141.7 | 0.26 |
| SMARCA4 SRX8566546 | 786-O Kidney | 1121 / 14979 (7.5%) | 21786 / 149790 (14.5%) | −143.6 | −141.6 | 0.51 |
| SMARCA4 SRX5982340 | A549 Lung | 102 / 14979 (0.7%) | 6275 / 149790 (4.2%) | −143.6 | −141.6 | 0.16 |
| TET2 SRX2014505 | Jurkat Blood | 2318 / 14979 (15.5%) | 12952 / 149790 (8.6%) | −143.1 | −141.2 | 1.79 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 249 / 14979 (1.7%) | 9061 / 149790 (6.0%) | −143.1 | −141.2 | 0.27 |
| ZEB1 SRX13298925 | MCF-7 Breast | 179 / 14979 (1.2%) | 7790 / 149790 (5.2%) | −143.0 | −141.0 | 0.23 |
| EP300 SRX1012648 | MCF-7 Breast | 132 / 14979 (0.9%) | 6876 / 149790 (4.6%) | −142.9 | −140.9 | 0.19 |
| MEAF6 DRX300417 | 293 Kidney | 1359 / 14979 (9.1%) | 6027 / 149790 (4.0%) | −142.8 | −140.9 | 2.25 |
| FOXA1 SRX028635 | MCF-7 Breast | 146 / 14979 (1.0%) | 7149 / 149790 (4.8%) | −142.7 | −140.7 | 0.20 |
| SMARCA4 SRX15419260 | 786-O Kidney | 1123 / 14979 (7.5%) | 21770 / 149790 (14.5%) | −142.7 | −140.7 | 0.52 |
| ESR1 SRX330070 | MCF-7 Breast | 150 / 14979 (1.0%) | 7222 / 149790 (4.8%) | −142.6 | −140.6 | 0.21 |
| FOXA1 SRX5203303 | MCF-7 Breast | 89 / 14979 (0.6%) | 5964 / 149790 (4.0%) | −142.6 | −140.6 | 0.15 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 261 / 14979 (1.7%) | 9245 / 149790 (6.2%) | −142.5 | −140.5 | 0.28 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 857 / 14979 (5.7%) | 18184 / 149790 (12.1%) | −142.2 | −140.3 | 0.47 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 782 / 14979 (5.2%) | 2481 / 149790 (1.7%) | −142.2 | −140.2 | 3.15 |
| ESR1 SRX1012632 | MCF-7 Breast | 142 / 14979 (0.9%) | 7051 / 149790 (4.7%) | −142.0 | −140.1 | 0.20 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 443 / 14979 (3.0%) | 12183 / 149790 (8.1%) | −141.9 | −140.0 | 0.36 |
| FOXA1 SRX6878603 | LNCAP Prostate | 342 / 14979 (2.3%) | 10583 / 149790 (7.1%) | −141.8 | −139.9 | 0.32 |
| RELA SRX7055007 | HAEC Cardiovascular | 588 / 14979 (3.9%) | 14361 / 149790 (9.6%) | −141.7 | −139.8 | 0.41 |
| SMAD3 SRX366168 | NCI-H441 Lung | 270 / 14979 (1.8%) | 9363 / 149790 (6.3%) | −141.3 | −139.4 | 0.29 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 693 / 14979 (4.6%) | 2015 / 149790 (1.3%) | −141.1 | −139.2 | 3.44 |
| ESR1 SRX8537722 | MCF-7 Breast | 298 / 14979 (2.0%) | 9825 / 149790 (6.6%) | −141.0 | −139.1 | 0.30 |
| FOXA1 SRX3923516 | MCF-7 Breast | 224 / 14979 (1.5%) | 8553 / 149790 (5.7%) | −141.0 | −139.1 | 0.26 |
| EP300 SRX10976215 | A549 Lung | 286 / 14979 (1.9%) | 9619 / 149790 (6.4%) | −140.8 | −138.8 | 0.30 |
| FOXA1 SRX219284 | LNCAP Prostate | 430 / 14979 (2.9%) | 11941 / 149790 (8.0%) | −140.8 | −138.8 | 0.36 |
| FOXA1 SRX9604647 | LNCAP Prostate | 487 / 14979 (3.3%) | 12815 / 149790 (8.6%) | −140.7 | −138.8 | 0.38 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 464 / 14979 (3.1%) | 12469 / 149790 (8.3%) | −140.7 | −138.8 | 0.37 |
| VGLL1 SRX18013277 | FULVR Breast | 120 / 14979 (0.8%) | 6554 / 149790 (4.4%) | −140.2 | −138.2 | 0.18 |
| ZFX SRX7805372 | 293 Kidney | 1376 / 14979 (9.2%) | 6198 / 149790 (4.1%) | −140.2 | −138.2 | 2.22 |
| SOX5 SRX2636544 | Hep G2 Liver | 311 / 14979 (2.1%) | 10008 / 149790 (6.7%) | −140.0 | −138.1 | 0.31 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 252 / 14979 (1.7%) | 9008 / 149790 (6.0%) | −140.0 | −138.0 | 0.28 |
| NR3C1 SRX10977372 | A549 Lung | 168 / 14979 (1.1%) | 7493 / 149790 (5.0%) | −139.9 | −138.0 | 0.22 |
| EP300 SRX22550927 | CDS1 Bone | 489 / 14979 (3.3%) | 12815 / 149790 (8.6%) | −139.8 | −137.9 | 0.38 |
| CEBPB SRX2194250 | SUM 159PT Breast | 387 / 14979 (2.6%) | 11233 / 149790 (7.5%) | −139.8 | −137.9 | 0.34 |
| FOXA1 SRX13814018 | 5637 Others | 187 / 14979 (1.2%) | 7844 / 149790 (5.2%) | −139.8 | −137.8 | 0.24 |
| FOXA1 SRX3923518 | MCF-7 Breast | 215 / 14979 (1.4%) | 8352 / 149790 (5.6%) | −139.7 | −137.8 | 0.26 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1110 / 14979 (7.4%) | 4467 / 149790 (3.0%) | −139.7 | −137.7 | 2.48 |
| ESR1 SRX2881000 | MCF-7 Breast | 280 / 14979 (1.9%) | 9476 / 149790 (6.3%) | −139.5 | −137.6 | 0.30 |
| FOXA1 SRX3931033 | MCF-7 Breast | 190 / 14979 (1.3%) | 7885 / 149790 (5.3%) | −139.4 | −137.5 | 0.24 |
| LEO1 SRX1873456 | SEM Blood | 1257 / 14979 (8.4%) | 5420 / 149790 (3.6%) | −139.4 | −137.4 | 2.32 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 347 / 14979 (2.3%) | 10575 / 149790 (7.1%) | −139.3 | −137.4 | 0.33 |
| FOS SRX3322637 | MCF-7 Breast | 152 / 14979 (1.0%) | 7159 / 149790 (4.8%) | −139.1 | −137.2 | 0.21 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 268 / 14979 (1.8%) | 9257 / 149790 (6.2%) | −139.1 | −137.1 | 0.29 |
| FOXA2 SRX10475773 | Hep G2 Liver | 396 / 14979 (2.6%) | 11337 / 149790 (7.6%) | −138.7 | −136.8 | 0.35 |
| FOXL2 SRX6957477 | KGN Gonad | 335 / 14979 (2.2%) | 10358 / 149790 (6.9%) | −138.6 | −136.7 | 0.32 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 429 / 14979 (2.9%) | 11848 / 149790 (7.9%) | −138.5 | −136.6 | 0.36 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 978 / 14979 (6.5%) | 19666 / 149790 (13.1%) | −138.5 | −136.5 | 0.50 |
| ESR1 SRX330069 | MCF-7 Breast | 190 / 14979 (1.3%) | 7855 / 149790 (5.2%) | −138.4 | −136.5 | 0.24 |
| ESR1 SRX3110725 | MCF-7 Breast | 288 / 14979 (1.9%) | 9571 / 149790 (6.4%) | −138.3 | −136.4 | 0.30 |
| ESR1 SRX1531796 | MCF-7 Breast | 161 / 14979 (1.1%) | 7309 / 149790 (4.9%) | −138.3 | −136.4 | 0.22 |
| NR3C1 SRX2609664 | HASM2 Lung | 454 / 14979 (3.0%) | 12213 / 149790 (8.2%) | −138.0 | −136.1 | 0.37 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 220 / 14979 (1.5%) | 8380 / 149790 (5.6%) | −137.8 | −135.9 | 0.26 |
| ARID5B SRX10475138 | Hep G2 Liver | 550 / 14979 (3.7%) | 13653 / 149790 (9.1%) | −137.8 | −135.9 | 0.40 |
| GATAD2A SRX2636507 | Hep G2 Liver | 349 / 14979 (2.3%) | 10556 / 149790 (7.0%) | −137.7 | −135.8 | 0.33 |
| TEAD3 SRX2636153 | Hep G2 Liver | 804 / 14979 (5.4%) | 17267 / 149790 (11.5%) | −137.6 | −135.7 | 0.47 |
| ESR1 SRX10365533 | MCF-7 Breast | 144 / 14979 (1.0%) | 6956 / 149790 (4.6%) | −137.5 | −135.6 | 0.21 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 192 / 14979 (1.3%) | 7863 / 149790 (5.2%) | −137.5 | −135.6 | 0.24 |
| FOXA1 SRX1961157 | T-47D Breast | 351 / 14979 (2.3%) | 10577 / 149790 (7.1%) | −137.4 | −135.5 | 0.33 |
| FOXA1 SRX1961158 | T-47D Breast | 319 / 14979 (2.1%) | 10051 / 149790 (6.7%) | −137.3 | −135.4 | 0.32 |
| ERG SRX063922 | K-562 Blood | 1380 / 14979 (9.2%) | 6285 / 149790 (4.2%) | −137.3 | −135.4 | 2.20 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 994 / 14979 (6.6%) | 3788 / 149790 (2.5%) | −137.2 | −135.3 | 2.62 |
| EP300 SRX717859 | HeLa Uterus | 153 / 14979 (1.0%) | 7123 / 149790 (4.8%) | −137.2 | −135.3 | 0.21 |
| FOXA1 SRX5323829 | T-47D Breast | 170 / 14979 (1.1%) | 7449 / 149790 (5.0%) | −137.2 | −135.3 | 0.23 |
| SS18 SRX10881848 | G-401 Kidney | 443 / 14979 (3.0%) | 12015 / 149790 (8.0%) | −137.1 | −135.2 | 0.37 |
| ZEB1 SRX13298924 | MCF-7 Breast | 141 / 14979 (0.9%) | 6883 / 149790 (4.6%) | −137.0 | −135.1 | 0.20 |
| NR3C1 SRX10977357 | A549 Lung | 188 / 14979 (1.3%) | 7770 / 149790 (5.2%) | −136.9 | −135.0 | 0.24 |
| SSRP1 SRX3436567 | HT-1080 Bone | 354 / 14979 (2.4%) | 519 / 149790 (0.3%) | −136.9 | −135.0 | 6.82 |
| FOXA3 SRX2630190 | Hep G2 Liver | 268 / 14979 (1.8%) | 9182 / 149790 (6.1%) | −136.8 | −134.9 | 0.29 |
| FOXA1 SRX6441748 | CFPAC-1 Pancreas | 91 / 14979 (0.6%) | 5847 / 149790 (3.9%) | −136.7 | −134.8 | 0.16 |
| AR SRX9109113 | MDA-MB-453 Breast | 635 / 14979 (4.2%) | 14833 / 149790 (9.9%) | −136.3 | −134.4 | 0.43 |
| WWTR1 SRX10119368 | MCF 10A Breast | 212 / 14979 (1.4%) | 8186 / 149790 (5.5%) | −136.2 | −134.3 | 0.26 |
| ESR1 SRX4451213 | MCF-7 Breast | 332 / 14979 (2.2%) | 10220 / 149790 (6.8%) | −136.0 | −134.1 | 0.32 |
| ARID1A SRX5089382 | MCF-7 Breast | 227 / 14979 (1.5%) | 8449 / 149790 (5.6%) | −136.0 | −134.1 | 0.27 |
| ARID1A SRX5679787 | 12Z Others | 107 / 14979 (0.7%) | 6166 / 149790 (4.1%) | −136.0 | −134.1 | 0.17 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 333 / 14979 (2.2%) | 10233 / 149790 (6.8%) | −135.8 | −134.0 | 0.33 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 313 / 14979 (2.1%) | 9902 / 149790 (6.6%) | −135.8 | −133.9 | 0.32 |
| KAT7 DRX234808 | 293 Kidney | 694 / 14979 (4.6%) | 2084 / 149790 (1.4%) | −135.6 | −133.7 | 3.33 |
| NFIL3 SRX2630334 | Hep G2 Liver | 256 / 14979 (1.7%) | 8935 / 149790 (6.0%) | −135.5 | −133.6 | 0.29 |
| NR3C1 SRX8520802 | HCC1187 Breast | 236 / 14979 (1.6%) | 8583 / 149790 (5.7%) | −135.3 | −133.4 | 0.27 |
| FOXA1 SRX9604645 | LNCAP Prostate | 464 / 14979 (3.1%) | 12260 / 149790 (8.2%) | −135.1 | −133.2 | 0.38 |
| CDK9 SRX7366783 | MCF-7 Breast | 221 / 14979 (1.5%) | 135 / 149790 (0.1%) | −135.0 | −133.2 | 16.37 |
| CEBPA SRX4705113 | MOLM-13 Blood | 778 / 14979 (5.2%) | 16798 / 149790 (11.2%) | −134.9 | −133.0 | 0.46 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 73 / 14979 (0.5%) | 5393 / 149790 (3.6%) | −134.9 | −133.0 | 0.14 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 399 / 14979 (2.7%) | 11254 / 149790 (7.5%) | −134.9 | −133.0 | 0.35 |
| GRHL3 SRX2582162 | NHEK Epidermis | 945 / 14979 (6.3%) | 3527 / 149790 (2.4%) | −134.9 | −133.0 | 2.68 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 283 / 14979 (1.9%) | 9372 / 149790 (6.3%) | −134.9 | −133.0 | 0.30 |
| STAT3 SRX2020847 | MDA-MB-468 Breast | 223 / 14979 (1.5%) | 8342 / 149790 (5.6%) | −134.9 | −133.0 | 0.27 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 441 / 14979 (2.9%) | 11901 / 149790 (7.9%) | −134.8 | −133.0 | 0.37 |
| SMARCA4 SRX5982341 | A549 Lung | 78 / 14979 (0.5%) | 5504 / 149790 (3.7%) | −134.7 | −132.9 | 0.14 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 387 / 14979 (2.6%) | 11055 / 149790 (7.4%) | −134.7 | −132.8 | 0.35 |
| CEBPB SRX190345 | MCF-7 Breast | 251 / 14979 (1.7%) | 8816 / 149790 (5.9%) | −134.5 | −132.7 | 0.28 |
| GATA3 SRX100559 | T-47D Breast | 367 / 14979 (2.5%) | 10731 / 149790 (7.2%) | −134.4 | −132.6 | 0.34 |
| FOXA1 SRX5203294 | MCF-7 Breast | 79 / 14979 (0.5%) | 5514 / 149790 (3.7%) | −134.4 | −132.5 | 0.14 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 212 / 14979 (1.4%) | 8124 / 149790 (5.4%) | −134.2 | −132.3 | 0.26 |
| FOXA1 SRX3923519 | MCF-7 Breast | 195 / 14979 (1.3%) | 7818 / 149790 (5.2%) | −134.1 | −132.3 | 0.25 |
| EP300 SRX717860 | HeLa Uterus | 197 / 14979 (1.3%) | 7849 / 149790 (5.2%) | −134.0 | −132.2 | 0.25 |
| JUN SRX150358 | HUVEC Cardiovascular | 201 / 14979 (1.3%) | 7916 / 149790 (5.3%) | −133.9 | −132.1 | 0.25 |
| ESR1 SRX1012629 | MCF-7 Breast | 202 / 14979 (1.3%) | 7933 / 149790 (5.3%) | −133.9 | −132.0 | 0.25 |
| NR3C1 SRX19024866 | MCF-7 Breast | 102 / 14979 (0.7%) | 6002 / 149790 (4.0%) | −133.8 | −132.0 | 0.17 |
| ESR1 SRX20282971 | MCF-7 Breast | 333 / 14979 (2.2%) | 10160 / 149790 (6.8%) | −133.8 | −131.9 | 0.33 |
| FOXA1 SRX3923515 | MCF-7 Breast | 177 / 14979 (1.2%) | 7474 / 149790 (5.0%) | −133.8 | −131.9 | 0.24 |
| NKX2-1 SRX366170 | NCI-H441 Lung | 242 / 14979 (1.6%) | 8635 / 149790 (5.8%) | −133.7 | −131.9 | 0.28 |
| ESR1 SRX5323873 | MCF-7 Breast | 414 / 14979 (2.8%) | 11438 / 149790 (7.6%) | −133.5 | −131.6 | 0.36 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 201 / 14979 (1.3%) | 7905 / 149790 (5.3%) | −133.5 | −131.6 | 0.25 |
| ESR1 SRX20282953 | MCF-7 Breast | 271 / 14979 (1.8%) | 9124 / 149790 (6.1%) | −133.4 | −131.5 | 0.30 |
| RXRB SRX2636027 | Hep G2 Liver | 359 / 14979 (2.4%) | 10568 / 149790 (7.1%) | −133.4 | −131.5 | 0.34 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 706 / 14979 (4.7%) | 2177 / 149790 (1.5%) | −133.2 | −131.4 | 3.24 |
| ING5 SRX286202 | RKO Digestive tract | 1131 / 14979 (7.6%) | 4719 / 149790 (3.2%) | −133.2 | −131.4 | 2.40 |
| ESR1 SRX3123829 | MCF-7 Breast | 183 / 14979 (1.2%) | 7568 / 149790 (5.1%) | −133.2 | −131.3 | 0.24 |
| GFP SRX6949256 | HeLa Uterus | 358 / 14979 (2.4%) | 10543 / 149790 (7.0%) | −133.1 | −131.3 | 0.34 |
| Epitope tags SRX10549778 | K-562 Blood | 974 / 14979 (6.5%) | 3734 / 149790 (2.5%) | −133.1 | −131.2 | 2.61 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 211 / 14979 (1.4%) | 8072 / 149790 (5.4%) | −133.0 | −131.2 | 0.26 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 474 / 14979 (3.2%) | 1027 / 149790 (0.7%) | −133.0 | −131.1 | 4.62 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 288 / 14979 (1.9%) | 9395 / 149790 (6.3%) | −132.9 | −131.1 | 0.31 |
| YAP1 SRX1038945 | IMR-90 Lung | 242 / 14979 (1.6%) | 8610 / 149790 (5.7%) | −132.9 | −131.0 | 0.28 |
| NANOG SRX10445309 | Neural crest cells Neural | 167 / 14979 (1.1%) | 7255 / 149790 (4.8%) | −132.8 | −130.9 | 0.23 |
| JUND SRX092301 | K-562 Blood | 439 / 14979 (2.9%) | 11793 / 149790 (7.9%) | −132.7 | −130.9 | 0.37 |
| NR3C1 SRX2609665 | HASM2 Lung | 365 / 14979 (2.4%) | 10638 / 149790 (7.1%) | −132.7 | −130.8 | 0.34 |
| FOXA1 SRX3931056 | MCF-7 Breast | 183 / 14979 (1.2%) | 7548 / 149790 (5.0%) | −132.6 | −130.7 | 0.24 |
| NR3C1 SRX10977373 | A549 Lung | 165 / 14979 (1.1%) | 7209 / 149790 (4.8%) | −132.5 | −130.6 | 0.23 |
| EP300 SRX10976625 | A549 Lung | 180 / 14979 (1.2%) | 7485 / 149790 (5.0%) | −132.4 | −130.5 | 0.24 |
| JUND SRX190303 | HCT 116 Digestive tract | 414 / 14979 (2.8%) | 11392 / 149790 (7.6%) | −132.3 | −130.5 | 0.36 |
| EP300 SRX1012643 | MCF-7 Breast | 105 / 14979 (0.7%) | 6022 / 149790 (4.0%) | −132.3 | −130.4 | 0.17 |
| KMT2C SRX1787675 | MCF-7 Breast | 294 / 14979 (2.0%) | 9467 / 149790 (6.3%) | −132.1 | −130.2 | 0.31 |
| FOXA1 SRX5323845 | MCF-7 Breast | 107 / 14979 (0.7%) | 6053 / 149790 (4.0%) | −132.0 | −130.2 | 0.18 |
| RNF2 SRX18954704 | FaDu Others | 805 / 14979 (5.4%) | 17050 / 149790 (11.4%) | −132.0 | −130.1 | 0.47 |
| NR3C1 SRX17639413 | A549 Lung | 221 / 14979 (1.5%) | 8206 / 149790 (5.5%) | −131.8 | −130.0 | 0.27 |
| SMARCA4 SRX5982364 | A549 Lung | 84 / 14979 (0.6%) | 5552 / 149790 (3.7%) | −131.7 | −129.8 | 0.15 |
| HOXC5 SRX2731653 | PC-3 Prostate | 259 / 14979 (1.7%) | 8862 / 149790 (5.9%) | −131.7 | −129.8 | 0.29 |
| MCM7 SRX8970972 | Squamous cell carcinoma Others | 376 / 14979 (2.5%) | 10774 / 149790 (7.2%) | −131.6 | −129.7 | 0.35 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 236 / 14979 (1.6%) | 8458 / 149790 (5.6%) | −131.4 | −129.6 | 0.28 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 643 / 14979 (4.3%) | 1863 / 149790 (1.2%) | −131.4 | −129.5 | 3.45 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 150 / 14979 (1.0%) | 6894 / 149790 (4.6%) | −131.4 | −129.5 | 0.22 |
| TP53 SRX19538272 | U2OS Bone | 471 / 14979 (3.1%) | 1027 / 149790 (0.7%) | −131.3 | −129.5 | 4.59 |
| RELA SRX7054617 | HAEC Cardiovascular | 403 / 14979 (2.7%) | 11188 / 149790 (7.5%) | −131.3 | −129.5 | 0.36 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 589 / 14979 (3.9%) | 1587 / 149790 (1.1%) | −131.3 | −129.5 | 3.71 |
| ARID1A SRX5679788 | 12Z Others | 126 / 14979 (0.8%) | 6419 / 149790 (4.3%) | −131.3 | −129.5 | 0.20 |
| NR3C1 SRX18884271 | A549 Lung | 165 / 14979 (1.1%) | 7172 / 149790 (4.8%) | −131.3 | −129.4 | 0.23 |
| JUNB SRX10119385 | MCF 10A Breast | 132 / 14979 (0.9%) | 6537 / 149790 (4.4%) | −131.2 | −129.4 | 0.20 |
| RNF2 SRX18954706 | SCC-25 Others | 417 / 14979 (2.8%) | 11399 / 149790 (7.6%) | −131.1 | −129.3 | 0.37 |
| MYC SRX150570 | MCF 10A Breast | 205 / 14979 (1.4%) | 7899 / 149790 (5.3%) | −131.0 | −129.2 | 0.26 |
Showing first 500 of 17846 rows.